Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Johns Hopkins Medicine Study Shows How Recently Approved Drug for Food Allergies Compares to Oral Immunotherapy, Whether It Allows Patients to Eat Their Food Allergens

New research, led by Johns Hopkins Children's Center investigators and sponsored by the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID), finds that omalizumab, a U.S. Food and Drug Administration-approved (FDA) injectable drug for food allergies, performed better than oral immunotherapy. A subsequent phase of the study also found that patients may be able to introduce allergenic foods into their diets after stopping the medicine.

March 2, 2025


March 13 2025

March 12 2025

March 11 2025

March 10 2025

March 9 2025

March 8 2025

March 7 2025

March 6 2025

March 5 2025

March 4 2025

March 3 2025

March 2 2025

February 28 2025